Why the study?
NT-proBNP has high prognostic value for CVD in RA, but its significance needed investigation in patients with RA refractory to or intolerant of basic anti-inflammatory therapy.
Answers are grounded in this paper and cite their sources.
In patients with rheumatoid arthritis resistant to basic therapy, NT-proBNP levels are elevated compared to healthy controls, though not significantly associated with brachiocephalic atherosclerosis in this small cohort.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Герасимова et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: